BNP Paribas Financial Markets’s Fibrocell Science Inc. FCSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1
| Closed | -$3 | – | 4558 |
|
|
2019
Q3 | $3 | Hold |
1
| – | – | ﹤0.01% | 4501 |
|
|
2019
Q2 | $2 | Hold |
1
| – | – | ﹤0.01% | 4529 |
|
|
2019
Q1 | $2 | Hold |
1
| – | – | ﹤0.01% | 4271 |
|
|
2018
Q4 | $2 | Hold |
1
| – | – | ﹤0.01% | 4313 |
|
|
2018
Q3 | $2 | Hold |
1
| – | – | ﹤0.01% | 4436 |
|
|
2018
Q2 | $3 | Buy |
+1
| New | +$3 | ﹤0.01% | 4411 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4222 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4224 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4228 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 4238 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 4070 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4153 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 3533 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3554 |
|
|
2016
Q1 | – | Sell |
-396
| Closed | -$27K | – | 3307 |
|
|
2015
Q4 | $27K | Buy |
396
+36
| +10% | +$2.59K | ﹤0.01% | 3179 |
|
|
2015
Q3 | $20.8K | Buy |
360
+224
| +165% | +$19.8K | ﹤0.01% | 3294 |
|
|
2015
Q2 | $10.8K | Buy |
+136
| New | +$9.15K | ﹤0.01% | 3323 |
|
|
2014
Q4 | – | Sell |
-30
| Closed | -$1.3K | – | 3585 |
|
|
2014
Q3 | $1.3K | Hold |
30
| – | – | ﹤0.01% | 3972 |
|
|
2014
Q2 | $1.79K | Buy |
+30
| New | +$1.67K | ﹤0.01% | 3173 |
|
|
2014
Q1 | – | Sell |
-19
| Closed | -$1.18K | – | 3981 |
|
|
2013
Q4 | $1.18K | Buy |
+19
| New | +$1.11K | ﹤0.01% | 3814 |
|
BNP Paribas Financial Markets's FCSC Position: Q4 2019 in Review
BNP Paribas Financial Markets sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 1 share — an estimated $3 sold.
BNP Paribas Financial Markets first reported a position in FCSC in Q4 2013 and held it in 12 quarters. The position peaked at $27K in Q4 2015. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.
- BNP Paribas Financial Markets reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
- BNP Paribas Financial Markets sold 1 Fibrocell Science Inc. share in Q4 2019, an estimated $3.
- BNP Paribas Financial Markets first reported a position in Fibrocell Science Inc. in Q4 2013 and held it in 12 quarters.
- BNP Paribas Financial Markets's Fibrocell Science Inc. position peaked at $27K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.